Supported by a strong scientific advisory board and engaged scientific founders
Prof. Peter Fraser, Co-Founder (Chair of Scientific Advisory Board)
Peter is a world-leading expert in gene expression and chromosomal architecture and the inventor of the GenLink3D platform. During the scientific discovery and early concept of the business, Peter led the Nuclear Dynamics Programme at the Babraham Institute in Cambridge, UK. Peter is Chair at Florida State University where he is Director of the Centre for Genomics and Personalised Medicine.
Dr. Stefan Schoenfelder, Co-Founder
Stefan is a recognised expert in the area of 3D genome organisation and function. Having led the development of Capture Hi-C while working in Prof. Fraser’s laboratory, Stefan is a group leader in the Epigenetics Programme at the Babraham Institute. He co-founded Enhanc3D in 2020 and continues to serve as CSO.
Dr. Louise Jopling, Strategic Advisor
Louise is an immunologist with extensive experience working across drug discovery, development and commercialisation domains within academia (University of Edinburgh, Imperial College London), biotech (Celltech) and pharmaceutical (UCB & Janssen/Johnson & Johnson Innovation) organisations.
Louise leads the commercial team at Eastern AHSN to develop partnerships and support innovators refine their business models, value propositions and navigate the NHS to maximise population benefit and generate economic growth at a regional and national level.
Louise has a BSc (hons) in Zoology (Parasitology) from the University of Aberdeen, a PhD in Immunology from Imperial College London and conducted her postdoctoral training at Boston Children’s Hospital, Harvard Medical School